2025. Narrative Review on Ibrutinib: A New Targeted Therapy for Hematologic Cancers. Asian Journal of Pharmaceutics (AJP). 19, 3 (Sep. 2025). DOI:https://doi.org/10.22377/ajp.v19i3.6728.